Search by Drug Name or NDC

NDC 61269-0660-20 ZYPREXA Details

ZYPREXA

ZYPREXA is a INTRAMUSCULAR KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by H2-Pharma LLC. The primary component is .

MedlinePlus Drug Summary

Olanzapine extended-release injection is used to treat schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Olanzapine injection is used to treat episodes of agitation in people who have schizophrenia or in people who have bipolar I disorder (manic depressive disorder; a disease that causes episodes of depression, episodes of severe mania, and other abnormal moods) and are experiencing an episode of mania (abnormally excited or irritated mood). Olanzapine is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.

Related Packages: 61269-0660-20
Last Updated: 04/28/2024
MedLinePlus Full Drug Details: Olanzapine Injection

Product Information

NDC	61269-0660
Product ID	61269-660_e1d8108e-ee35-46db-9f64-2e117862e6fc
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	ZYPREXA
Proprietary Name Suffix	Relprevv
Non-Proprietary Name	Olanzapine pamoate
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	KIT
Route	INTRAMUSCULAR
Active Ingredient Strength	n/a
Active Ingredient Units	n/a
Substance Name	n/a
Labeler Name	H2-Pharma LLC
Pharmaceutical Class	n/a
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA022173
Listing Certified Through	2024-12-31

Package

NDC 61269-0660-20 (61269066020)

Pricing Information	N/A
NDC Package Code	61269-660-20
Billing NDC	61269066020
Package	1 KIT in 1 CARTON (61269-660-20) * 1.4 mL in 1 VIAL (61269-663-01) * 3 mL in 1 VIAL (61269-670-01)
Marketing Start Date	2010-03-01
NDC Exclude Flag	N